Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.
about
Examination of genetic variants involved in generation and biodisposition of kinins in patients with angioedemaCLIF, a novel cycle-like factor, regulates the circadian oscillation of plasminogen activator inhibitor-1 gene expressionA PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology GroupIncreased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphismNo Association of SERPINE1 -675 Polymorphism With Sepsis Susceptibility: A Meta-AnalysisAssociation between the SERPINE1 (PAI-1) 4G/5G insertion/deletion promoter polymorphism (rs1799889) and pre-eclampsia: a systematic review and meta-analysisPolymorphism 4G/5G in the plasminogen activator inhibitor-1 (PAI-1) gene is associated with IgE-mediated allergic diseases and asthma in the Czech populationProgression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expressionGenome-wide association study for circulating levels of PAI-1 provides novel insights into its regulationTransgenic over-expression of plasminogen activator inhibitor-1 results in age-dependent and gender-specific increases in bone strength and mineralization.MALDI-TOF mass spectrometry-based SNP genotyping.Epistatic interactions in genetic regulation of t-PA and PAI-1 levels in a Ghanaian population.The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group.The role of TPA I/D and PAI-1 4G/5G polymorphisms in multiple sclerosis.The study of t-PA, u-PA and PAI-1 genes polymorphisms in patients with abdominal aortic aneurysm.The 4G/4G genotype of the PAI-1 (serpine-1) 4G/5G polymorphism is associated with decreased lung allograft utilizationCardiovascular risk associated with interactions among polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systemsThrombophilia, polymorphisms, and vascular disease4G/5G polymorphism of PAI-1 gene is associated with multiple organ dysfunction and septic shock in pneumonia induced severe sepsis: prospective, observational, genetic studySignificant associations of PAI-1 genetic polymorphisms with osteonecrosis of the femoral headThe impact of molecular medicine upon early cardiovascular drug development.Plasminogen activator inhibitor type 1 gene polymorphism and sepsis.4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with mortality in intensive care unit patients with severe pneumoniaThe role of plasminogen activator inhibitor-1 and angiotensin-converting enzyme gene polymorphisms in bronchopulmonary dysplasia.Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditionsThe -675 4G/5G polymorphism in plasminogen activator inhibitor-1 gene is associated with risk of asthma: a meta-analysisPlasminogen activator inhibitor-1 4G/5G gene polymorphism and coronary artery disease in the Chinese Han population: a meta-analysis.Plasminogen activator inhibitor-1 gene polymorphism in Iranian Azeri Turkish patients with FMF disease and its association with amyloidosis.Invited review: Pharmacogenetics of estrogen replacement therapy.Gene polymorphisms of the haemostatic system and the risk of arterial thrombotic disease.Anticoagulant therapy for osteonecrosis associated with heritable hypofibrinolysis and thrombophilia.Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis.Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with coronary artery disease risk: a meta-analysisAssociation between plasminogen activator inhibitor-1 -675 4G/5G polymorphism and sepsis: a meta-analysisPAI-1 4G/5G polymorphism contributes to cancer susceptibility: evidence from meta-analysisGenes and abdominal aortic aneurysm.MTHFR Glu429Ala and ERCC5 His46His polymorphisms are associated with prognosis in colorectal cancer patients: analysis of two independent cohorts from Newfoundland.A common polymorphism in the promoter region of the TNFSF4 gene is associated with lower allele-specific expression and risk of myocardial infarction.PAI-1 -675 4G/5G polymorphism in association with diabetes and diabetic complications susceptibility: a meta-analysis study.Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes.
P2860
Q23915359-5755D206-57B3-4C2E-B2EE-D2CE2A13D67BQ24290360-27B91A31-65C5-4174-B0BE-49919F9A00F2Q24656610-CF63CFE8-2530-4EE6-8EA2-08EBFA0A6073Q24815761-A4DAA695-5F01-48EF-8F58-50728646FBEAQ26777554-9BEB362D-E06F-47B7-833B-5D7D4F24B669Q26821944-75D5EA74-29DE-4FE3-8D66-62C94D210CE3Q28215651-531C3E5A-FCD0-4668-990E-9509FA6C060CQ28281614-454D07E7-44A7-457D-8D28-535085A6AFF9Q30415902-6D3401B6-87D8-43E0-A2A7-519DD6F6D9CCQ30442725-0FA6072B-1BCA-4029-BF5D-1DD44249972FQ30841256-397E4EF8-DDEC-492D-8FFB-EC5C6B3D19AFQ30999425-96052384-4F1A-4D2E-85C3-E770F421345EQ31899830-64A6D610-985A-4928-ABDC-3D0FB27740BFQ33562755-A36114D7-4965-4F8D-9F1E-3CF9B63552CDQ33579837-F4273D58-1CFE-4EB2-BEA1-0530C62DBA67Q33599073-1B3AD08D-3C16-4259-847E-C9768860BDA9Q33697706-988800E3-8FE7-4FCD-AB7F-6C02473E3192Q33918597-68A6B953-CD3F-43E5-99CA-51AA3B776D13Q33919345-00F496BE-57B6-4F7A-9A3C-51CA8684729CQ33959926-46E1491B-2C2F-42CD-B1FA-FBF585FF260DQ33962018-0F871BB8-890E-43F1-B523-8FA4921D0CE3Q33990846-BB84FA80-F691-4A92-A9C0-2EDB7165F3C7Q34022566-C01CFE2B-1A75-4650-8B2F-5466C630EC91Q34211497-0D951E4D-EC66-4366-9B67-44B9429491EEQ34217461-44E595B7-98B8-4AA6-8C54-12378478A7F6Q34222527-FA3A7442-A40B-4F67-9288-737045E2CFD0Q34229863-D9CC3862-1141-4F78-BE5D-B81814CDEADBQ34439639-7A3A6BFC-197A-41E2-BF2B-C4C52F6201FCQ34444907-726C59DC-3160-421B-9A9F-B8A13F85F005Q34459073-A083A912-CC0B-4D8F-8F45-2131B564000DQ34481574-3B6F8508-A0E8-4C6D-9CE5-00D7A8A86F40Q34529991-B5304EC8-159B-4324-9FE9-1A425AA5B5A5Q34547819-F8DF4E0B-B6B5-4860-BDD7-08D533B7CA31Q34575766-D4BE07C7-DA6C-4D61-AAC8-96A2A43FCAE0Q34599478-1A1D080C-4261-4847-A2DE-A9599A8D7840Q34683905-65FE6A64-02E8-4A8B-A9F4-972FCAB15C84Q34692175-66906A51-E0DD-47FB-B0D1-3B2F8D784154Q34698996-D143AE5F-07EB-43D5-B7CB-75018E64F6C1Q35041179-59A5ABC1-F851-4C53-B5D5-2F33EAC8FFF9Q35053963-9CB5C727-AB0D-493A-819F-58F4AC66B24F
P2860
Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Allele-specific increase in ba ...... ed with myocardial infarction.
@ast
Allele-specific increase in ba ...... ed with myocardial infarction.
@en
Allele-specific increase in ba ...... ed with myocardial infarction.
@nl
type
label
Allele-specific increase in ba ...... ed with myocardial infarction.
@ast
Allele-specific increase in ba ...... ed with myocardial infarction.
@en
Allele-specific increase in ba ...... ed with myocardial infarction.
@nl
prefLabel
Allele-specific increase in ba ...... ed with myocardial infarction.
@ast
Allele-specific increase in ba ...... ed with myocardial infarction.
@en
Allele-specific increase in ba ...... ed with myocardial infarction.
@nl
P2093
P2860
P356
P1476
Allele-specific increase in ba ...... ed with myocardial infarction.
@en
P2093
Båvenholm P
van 't Hooft FM
P2860
P304
P356
10.1073/PNAS.92.6.1851
P407
P577
1995-03-01T00:00:00Z